Aug 29, 2024 / 08:30PM GMT
Operator
Good afternoon, and thank you for standing by. Welcome to Kane Biotech second-quarter 2024 earnings conference call. (Operator Instructions) This conference is being recorded today, August 29, 2024. I would now like to turn the conference over to Ray Dupuis, Kane Biotech's, Chief Financial Officer. Please go ahead.
Raymond Dupuis - Kane Biotech Inc - Chief Financial Officer
Thank you, operator. Good afternoon, and welcome, everyone to Kane Biotech's second-quarter 2024 earnings conference call. We were delighted to have you join us today. This call will cover Kane's financial and operating results, along with a discussion of some of our recent highlights and goals for the remainder of 2024 and beyond. Following our prepared remarks, we will open the conference call to question and answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.
Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward looking information and statements within
Q2 2024 Kane Biotech Inc Earnings Call Transcript
Aug 30, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers